The differential growth of skeletal muscle in the pre- and post-natal environment is important to this story because proof of concept efficacy of myostatin inhibition in animal models of DMD was initially proven through MSTN knockout (KO), which manipulates both pre- and post-natal hyperplastic and hypertrophic muscling [22]. Here, MSTN is linked to Duchenne muscular dystrophy.